| Serial Number | 79281970 |
| Word Mark | INPHARMA RESEARCH · DEVELOP PRODUCE |
| Filing Date | Monday, September 30, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 8, 2021 |
| Registration Number | 6375070 |
| Registration Date | Tuesday, June 8, 2021 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 23, 2021 |
| Indication of Colors claimed | The color(s) gold and blue is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of a design of four rectangles with two curved corners each, wherein the top left rectangle is in gold and is larger than the other three rectangles, and the other three rectangles are in blue, and wherein the rectangles design is to the left of the wording "INPHARMA", wherein the wording "IN" is in gold and "PHARMA" is in blue, above the wording "RESEARCH DEVELOP PRODUCE" in blue with blue dots between this wording. |
| Goods and Services | Foodstuffs and dietetic substances for medical and veterinary purposes, namely, dietary supplements, food grade products being capsules sold empty for pharmaceuticals, infant food for medical purposes, Organic food supplements, organic dietary supplements, powder food supplements, liquid food supplements, dietary supplements that are sold in a container cap for subsequent delivery into liquids, newborn food supplements, infant food supplements, wellness dietary supplements, natural dietary supplements for the treatment of the mental health, nutritionally complete dietetic foods with a standard nutrient formulation adapted for medical purposes, nutritionally complete dietetic foods with a nutrient-adapted formulation specific for a disease, nutritionally incomplete dietetic foods with a standard formulation or a nutrient-adapted formulation specific for a disease; dietetic and nutritional preparations for medical use; infant formula; dietetic substances for babies for medical purposes; dietary supplements for infants; dietary supplements for humans and animals; food supplements; dietary food supplements, not for medical purposes; dietary supplements; nutritional supplements; dietary supplement drink mixes; dietary supplemental drinks; dietetic beverages adapted for medical purposes; multi-vitamin preparations; vitamins and vitamin preparations; dietary supplements for athletes; powdered nutritional supplement drink mix; dietetic foodstuffs for medical purposes, namely, dietary supplements; probiotic supplements; prebiotic supplements; probiotic bacterial formulations for medical use, namely, probiotic supplements; probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system; milk ferments for pharmaceutical purposes; pharmaceutical preparations and substances for treating constipation or diarrhoea; pharmaceutical preparations and substances, namely, Antioxidants, nutritional supplements for boosting energy, Multivitamins, Sleeping pills/tablets, Immunostimulants, oral Rehydration salts, Vitamins, skin Enhancers being medicated skin care preparations, Nasal sprays, Amino acids, Antiemetic preparations, nutritional supplements consisting primarily of iron, Anti-inflammatories, lozenges to relieve sore throat, cough syrups, anti-obesity diet capsules; medicinal preparations and substances for treating constipation or diarrhoea; medicinal preparations and substances, namely, nutritional supplements for boosting energy, Multivitamins, Sleeping pills/tablets, Immunostimulants, oral Rehydration salts, Vitamins, skin Enhancers being medicated skin care preparations, Nasal sprays, Amino acids, Antiemetic preparations, nutritional supplements consisting primarily of iron, Anti-inflammatories, lozenges to relieve sore throat, cough syrups, anti-obesity diet capsules; antibacterial substances for medical purposes; diagnostic substances for medical use; astringents for medical purposes; pharmaceutical antiallergic preparations and substances; bactericides; medical devices based on substances, namely, delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements, nasal sprays for cold symptoms, sprays to relieve sore throat |
| Pseudo Mark | IN PHARMA RESEARCH DEVELOP PRODUCE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 31, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Inpharma S.p.A. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | IT |
| Party Name | Inpharma S.p.A. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | IT |
| Party Name | Inpharma S.p.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | IT |
| Event Date | Event Description |
| Sunday, October 24, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, September 28, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, September 27, 2021 | FINAL DISPOSITION PROCESSED |
| Wednesday, September 8, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, June 8, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 23, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 23, 2021 | PUBLISHED FOR OPPOSITION |
| Sunday, March 21, 2021 | NOTIFICATION PROCESSED BY IB |
| Wednesday, March 3, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, March 3, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, March 3, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, February 18, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, February 18, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, February 18, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, February 18, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, February 18, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, February 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 9, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, February 6, 2021 | ASSIGNED TO LIE |
| Tuesday, November 3, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, May 23, 2020 | REFUSAL PROCESSED BY IB |
| Sunday, May 3, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, May 3, 2020 | REFUSAL PROCESSED BY MPU |
| Wednesday, April 22, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, April 21, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, April 4, 2020 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, March 31, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, March 31, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, March 26, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |